Valuation: Captor Therapeutics Spolka Akcyjna

Market Cap 426M 109M 97.26M 90.77M 82.74M 156M 10.52B 157M 1.1B 5.38B 411M 402M 17.26B P/E 2026 *
21.8x
P/E 2027 * -10.4x
Enterprise Value 353M 90.82M 80.69M 75.31M 68.65M 129M 8.73B 131M 911M 4.46B 341M 334M 14.32B EV / Sales 2026 *
6.23x
EV / Sales 2027 * 39.4x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week-4.42%
Current month-3.74%
1 month-6.29%
3 months-10.43%
6 months-17.08%
Current year-6.94%
1 week 63.2
Extreme 63.2
71
1 month 63.2
Extreme 63.2
74.8
Current year 63.2
Extreme 63.2
89.2
1 year 37.6
Extreme 37.6
89.2
3 years 31.2
Extreme 31.2
109.5
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 31/05/2025
Director of Finance/CFO - 01/02/2025
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Chairman 54 30/06/2022
Director/Board Member 74 30/06/2022
Director/Board Member - 30/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/26 A Buy 1,100 0.0198%
12/12/25 A Free

Chairman

360,074 6.5128%
12/12/25 A Don

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-4.42%+76.32%-33.00% 109M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+20.19%+81.44% 57.39B
+0.89%-0.63%+2.17%+36.19% 47.64B
+0.36%+0.81%+342.39%+742.40% 44.29B
-0.96%-4.50%+24.96%+35.38% 42.5B
-0.20%-0.77%+4.13%+105.50% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.33%+22.72% 28.53B
+0.05%-1.64%-8.14%-11.37% 24.34B
Average -0.35%-0.97%+55.00%+112.39% 39.06B
Weighted average by Cap. +0.12%-0.84%+56.96%+138.21%

Financials

2026 *2027 *
Net sales 56.7M 14.58M 12.95M 12.09M 11.02M 20.78M 1.4B 20.98M 146M 717M 54.74M 53.55M 2.3B 10M 2.57M 2.28M 2.13M 1.94M 3.67M 247M 3.7M 25.81M 126M 9.65M 9.45M 406M
Net income -3M -771K -685K -640K -583K -1.1M -74.16M -1.11M -7.74M -37.91M -2.9M -2.83M -122M -41M -10.54M -9.37M -8.74M -7.97M -15.03M -1.01B -15.17M -106M -518M -39.58M -38.72M -1.66B
Net Debt -72.5M -18.64M -16.56M -15.46M -14.09M -26.58M -1.79B -26.82M -187M -916M -70M -68.48M -2.94B -32M -8.23M -7.31M -6.82M -6.22M -11.73M -791M -11.84M -82.58M -404M -30.89M -30.22M -1.3B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
-
Date Price Change Volume
02/10/26 PLN 67.00 -1.47% 1,547
01/10/26 PLN 68.00 -2.30% 6,436
30/09/26 PLN 69.60 -0.57% 4,875
29/09/26 PLN 70.00 -1.13% 101
28/09/26 PLN 70.80 +1.00% 626
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
67.00PLN
Average target price
86.83PLN
Spread / Average Target
+29.60%

Quarterly revenue - Rate of surprise